Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$36.89 - $56.88 $60.9 Million - $93.9 Million
-1,650,000 Reduced 50.43%
1,621,829 $75.7 Million
Q4 2022

Feb 07, 2023

SELL
$33.44 - $54.8 $54.7 Million - $89.7 Million
-1,636,000 Reduced 33.33%
3,271,829 $179 Million
Q4 2021

Jan 27, 2022

BUY
$19.87 - $26.24 $97.5 Million - $129 Million
4,907,829 New
4,907,829 $104 Million

Others Institutions Holding AKRO

About Akero Therapeutics, Inc.


  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.38B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Skorpios Trust Portfolio

Follow Skorpios Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skorpios Trust, based on Form 13F filings with the SEC.

News

Stay updated on Skorpios Trust with notifications on news.